- ADCHEM Insights
News, analysis, and
technical perspective.
Principal partnerships, formulation guidance, regulatory updates, and the industry events where you'll find our teams — published when we have something worth saying.
Hypromellose viscosity grade selection for sustained-release matrix tablets: a practical guide for formulators in MENA markets.
Selecting the right HPMC viscosity grade is the single most consequential decision in a hydrophilic matrix sustained-release formulation. This guide covers the relationship between HPMC molecular weight, polymer concentration, and release rate — applied to the grades stocked and distributed by ADCHEM across the Gulf, Egypt, Turkey, and Pakistan.
Recent articles & news
Beyond the Raw Material
ADCHEM’s Role in Excipient Innovation and Formulation Success
In recent years, the global pharmaceutical supply chain has faced unprecedented turbulence. From pandemic-era logistics gridlock to regional conflicts and geopolitical shifts, sourcing raw materials and excipients has become a high-stakes challenge. In an industry where a single missing component ....
Resilient Supply Chains in Pharma
How ADCHEM Keeps Production Lines Moving Through Global Uncertainty
Navigating the landscape of pharmaceutical excipients is a masterclass in balancing scientific ambition with stringent regulatory realities. When industry discussions turn to innovation, the term “new excipient” is often thrown around loosely, but its practical definition is far more nuanced....
Beyond Traditional Tablets:
Why Liquid-Filled Capsules Are Changing the Market
The dietary supplement and functional food markets are moving faster than ever. As consumers increasingly demand higher efficacy, cleaner labels, and faster absorption, traditional powder-filled capsules and standard compressed tablets are often no longer enough to make a brand .....
Beyond Traditional Tablets:
Why Liquid-Filled Capsules Are Changing the Market
The dietary supplement and functional food markets are moving faster than ever. As consumers increasingly demand higher efficacy, cleaner labels, and faster absorption, traditional…
Read Article →
Resilient Supply Chains in Pharma:
How ADCHEM Keeps Production Lines Moving Through Global Uncertainty
In recent years, the global pharmaceutical supply chain has faced unprecedented turbulence. From pandemic era logistics gridlock to regional conflicts and geopolitical shifts, sourcing…
Read Article →
Beyond the Raw Material:
ADCHEM’s Role in Excipient Innovation and Formulation Success
Navigating the landscape of pharmaceutical excipients is a masterclass in balancing scientific ambition with stringent regulatory realities. When industry discussions turn to innovation, the…
Read Article →Where to find ADCHEM
Announcements & releases
ADCHEM opens Lahore formulation laboratory — second R&D facility in the group
The Lahore lab mirrors the Bergamo cosmetics formulation capability, adding South Asia-focused development capacity for personal care, topicals and cost-engineered formulations for MENA markets.
Mibelle Biochemistry distribution extended to South Asia and East Africa
ADCHEM extends its Mibelle Biochemistry distribution agreement. The PhytoCellTec™, AnaGain™ and DracoBelle™ Nu lines are now actively distributed across Lahore, Karachi, and Islamabad.
Successful renewal of EXCiPACT certification covering pharmaceutical excipient distribution across Dubai, Bergamo, and Lahore. Audit completed with zero major non-conformances.
ADCHEM CarboPrime line receives Halal certification for MENA pharmaceutical market
CarboPrime 40 — ADCHEM’s general-purpose carbomer grade — has received Halal certification, enabling its use in pharmaceutical topical preparations across GCC, Egypt, and Pakistan markets requiring Halal documentation.
ADCHEM establishes new trading entity in Shanghai — East Asia market coverage begins
Shanghai ADCHEM Chemical Co. Ltd. is now operational in Jinshan District. The office provides commercial and sourcing coverage across the East Asia region, completing ADCHEM’s ten-office global footprint.
Technical updates and formulation guidance.
Infrequent and targeted — we publish when we have something worth reading. Technical formulation briefs, regulatory updates, and principal news. No marketing, no cadence obligation.